Cargando…
Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2
Hypomyopathic dermatomyositis (DM) presents with cutaneous lesions consistent with dermatomyositis but in the absence of clinically appreciable muscle weakness. The cutaneous manifestations are often refractory and more resistant to conventional therapy than concomitant muscle involvement. We presen...
Autores principales: | Miao, Miao, Li, Yuhui, Huang, Bo, He, Jing, Li, Zhanguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477052/ https://www.ncbi.nlm.nih.gov/pubmed/32648206 http://dx.doi.org/10.1007/s13555-020-00421-8 |
Ejemplares similares
-
9. Hypomyopathic dermatomyositis complicated by mannose-binding lectin deficiency
por: Al-Attar, Mariam, et al.
Publicado: (2019) -
45. A rare case of macrophage activation syndrome (MAS) associated with hypomyopathic dermatomyositis
por: Borukhson, Liubov, et al.
Publicado: (2018) -
Hypomyopathic Dermatomyositis Presenting with Idiopathic CD4 T-lymphocytopenia and Delayed Anti-MDA5 Positivity
por: Mijares, Maria C, et al.
Publicado: (2019) -
Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study
por: Zhufeng, Yunzhi, et al.
Publicado: (2022) -
Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study
por: Miao, Miao, et al.
Publicado: (2021)